Coronary Stents Market
Coronary Stents Market Analysis By Product (Bare Metal Stents, Drug Eluting Stents, Bio-absorbable Stents) and Region - Global Market Insights 2023 to 2033
Analysis of Coronary Stents Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Coronary Stents Market Overview (2023 to 2033)
The global coronary stents market size is valued at US$ 13.7 Billion in 2023, and is projected to reach US$ 38.5 Billion by 2033, at a growing Compound Annual Growth Rate (CAGR) of 10.8% during the forecast period from 2023 to 2033.
Coronary stenting is recommended for patients who have a blocked coronary artery. For individuals with acute coronary artery blockages, angioplasty is the first line of treatment. Over the previous decade, the number of patients receiving stenting has been increasing steadily and is slated to follow a similar trend in the future as well.
Rising coronary stent sales can be attributed to the development of outpatient coronary stenting, which minimizes the need for extended hospitalization. Furthermore, bio-absorbable coronary scaffolds are more beneficial than drug-eluting stents in the treatment of coronary occlusion.
Additional benefits of stenting treatments include improved blood flow and the prevention of additional heart muscle injury. It also helps to alleviate heart disease symptoms including angina and shortness of breath, lowering the need for coronary bypass surgery. As a result, surgeons favor stenting since it is a minimally invasive surgery with a quick recovery time.
As the geriatric population of the world expands, the number of people suffering from serious cardiovascular illnesses grows. Hypertension and increased total serum cholesterol levels are also contributing to the high incidence of heart diseases and boosting coronary stent demand through 2033.
Obesity is also a major risk factor for a variety of cardiovascular disorders around the world. Obesity or excessive weight creates an inappropriate or excessive accumulation of fats inside the artery lumen, which can lead to a variety of health issues, including coronary heart disease. As a result, weight loss and obesity management are critical components in avoiding cardiovascular disease.
All of the aforementioned prospects are slated to influentially govern coronary stents market revenue share across the forecast period and beyond. New coronary stent companies are focusing on innovation and raising new capital to fund their R&D efforts.
- In October 2021, Open Stent Solution (OSS), a medical technology company founded in 2018, announced that it had raised around US$ 2.7 million in a seed capital raise. The company focuses on the development of open-stent heart valves and intended to use the raised financing to support the R&D of its ribbon-shaped stented mitral valve.
| Report Attributes | Details |
|---|---|
|
Coronary Stents Market Size (2023) |
US$ 13.7 Billion |
|
Projected Market Value (2033F) |
US$ 38.5 Billion |
|
Global Market Growth Rate (2023 to 2033) |
10.8% CAGR |
|
Market Share of Drug Eluting Stents (2023) |
80% |
|
North America Market Share (2023) |
30% |
|
Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Barriers Must Coronary Stent Companies Overcome to Succeed in the Future?
“Stringent Regulations for Product Approval and Side-effects Associated with Coronary Stents”
One of the primary factors impeding market expansion is product failure and recall. Stent deformation and plaque prolapse are common issues that occur in coronary stents and such product failures result in serious patient consequences, prompting the product's removal from the market. This not only hurts the manufacturer financially but also has a negative impact on its reputation in the global marketplace.
Despite the growing need for therapeutic options, the negative side effects associated with coronary stents’ use may limit growth to some extent. Furthermore, tight government restrictions governing product approval will stifle market expansion.
Coronary stent market growth is also estimated to be hampered by the high cost of treatments involving coronary stents and the growing availability of alternative treatment methods for coronary artery disorders. Know more about other challenges and trends such as local supply, pricing trends, product standards, safety regulations, and new developments from this informative coronary stents market research report compiled by the skilled analysts at Fact.MR, a market research and competitive intelligence provider to give the reader a better understanding of the current and future market scope.
Country-wise Insights
Why is China a Key Market for Coronary Stent Manufacturers?
“Ongoing Clinical Trials for Effective Treatments to Expand Market Size”
Demand for coronary stents in China is forecasted to rise at a higher CAGR as compared to other Asian countries over the next ten years. Adoption of a sedentary lifestyle, poor eating habits, and expanding senescent population are prime factors driving market growth in this country.
Furthermore, coronary stent sales are extrapolated to be driven by an increase in the number of stent implantation procedures and a surge in the adoption of coronary stents. Increasing healthcare expenditure from private and public domains is also predicted to bolster market growth in the long term. In addition, ongoing clinical trials for the development of novel, effective, and safe treatments are driving market expansion in China.
What Makes the United States a Lucrative Market for Coronary Stent Producers?
“Rising Investments towards Coronary Stent Innovation Boosting Market Value”
Growing incidence of cardiovascular disorders and expanding geriatric population are projected to be primary aspects promulgating shipments of coronary stents in the United States throughout the forecast period.
- According to the National Center for Health Statistics, coronary artery disorders (CAD) cause 1 in 4 fatalities in the United States each year, with 785,000 people experiencing their first heart attack and 470,000 suffering from myocardial infarction.
Surging coronary stent sales in the United States are also being boosted by the establishment of specialty clinics and increased investments in coronary stent innovations. Furthermore, the presence of key coronary stent manufacturers in the United States is a huge growth enhancer.
Why are European Countries on the Watchlist of Coronary Stent Suppliers?
“Increasing Investments in R&D of Novel Cardiovascular Disease Treatment”
Incidence of cardiovascular disorders in European countries such as Germany, France, Italy, and the United Kingdom is increasing rapidly. Public and private health institutions are investing heavily in the research and development of novel treatments to help reduce the mortality rates of people suffering from heart diseases.
- In April 2023, Terumo Europe N.V., the European arm of a leading Japanese medical device company, announced the start of its new clinical study for a coronary stent system, which received a CE mark approval in November 2022. The study explores the use of Ultimaster Nagomi™ sirolimus eluting coronary stent system in complex PCI patients.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Category-wise Insights
Which Type of Stents is Most Popular?
“Preference for Drug Eluting Stents Remains Higher than Other Types”
At present, sales of drug eluting stents (DES) account for more than 80% of the global coronary stents market share, owing to benefits such as lower re-obstruction rates and better treatment outcomes.
Drug eluting stents are also employed in a variety of applications, including percutaneous coronary intervention and myocardial infarction in specialty clinics. In addition, several industry leaders are investing in R&D to produce technologically enhanced drug eluting stents. The industry revenue will be boosted by the use of DES in numerous applications and technological advancements.
- In August 2022, Medtronic, a renowned name in the global medical technology space, announced the launch of its new drug-eluting stent. The Onyx Frontier was branded as the most deliverable DES owing to its updated design and improved flexibility.
In general, drug eluting stents are less likely to develop restenosis than bare metal stents. Drug eluting stents are used to treat a blockage of the cardiac arteries. The market is growing due to leading manufacturers' introduction of novel medications in eluting stents and their widespread distribution around the world.
Competitive Landscape
Leading coronary stent companies are focusing on acquisitions, mergers, and collaborations to expand their business potential and secure their dominance in the global marketplace.
- In February 2023, Olympus, a leading Japanese medical device manufacturer, announced that it had acquired Taewoong Medical, a stent maker based in South Korea at US$ 370 million. This deal is the result of Olympus’ efforts to expand its medical device offerings and expand its revenue generation potential.
- In February 2021, Cardiovascular Systems Inc., a United States-based medical device company, announced that it had partnered with Chansu Vascular Technologies, to develop new peripheral and coronary balloons.
Coronary stent providers are also striving to gain approvals for their novel offerings that allow them to enter new regions and target new demographic thereby raking in loads of cash.
- In 2021, Biotronik, a multinational cardiovascular biomedical research organization based in Germany, announced that its Orsiro Mission bioabsorbable polymer coronary drug-eluting stent system (BP-DES) was approved by the United States Food and Drug Administration (FDA).
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Key Segments Covered in Coronary Stents Industry Research
-
By Product :
- Bare Metal Stents
- Drug Eluting Stents
- Bio-absorbable Stents
-
By Region :
- North America
- Latin America
- Europe
- APAC
- MEA
Table of Content
1. Executive Summary 1.1. Global Market Snapshot 1.2. Key Market Trends 1.3. Current Market & Future Potential 1.4. Fact.MR Recommendation 2. Market Overview 2.1. Market Segmentation 2.2. Market Indicators 2.3. Market Definitions 2.4. Market Dynamics 2.4.1. Drivers 2.4.2. Restraints 2.4.3. Opportunities 2.5. Porter’s Five Forces Analysis 2.6. Value Chain Analysis 2.6.1. List of Potential Customers 2.7. Global Market Analysis and Forecast, 2023-2033 3. COVID-19 Impact on Global Market 4. Market Outlook, by Region 5. Market Trend Analysis, 2023-2033 5.1. By Region 6. Global Market Analysis and Forecast, by Product, 2023-2033 6.1. Introduction & Definitions 6.2. Global Market Value (Mn) Forecast, by Product, 2023-2033 6.2.1. Bare Metal Stents 6.2.2. Drug Eluting Stents 6.2.3. Bio-absorbable Stents 6.3. Global Market Attractiveness, by Product 7. Global Market Analysis and Forecast, by Region, 2023-2033 7.1. Key Findings 7.2. Global Market Value (Mn) Forecast, by Region, 2023-2033 7.2.1. North America 7.2.2. Europe 7.2.3. Asia Pacific 7.2.4. Middle East & Africa 7.2.5. Latin America 7.3. Global Market Attractiveness, by Region 8. North America Market Analysis and Forecast, 2023-2033 8.1. Key Findings 8.2. North America Market Value (Mn) Forecast, by Product, 2023-2033 8.3. North America Market Value (Mn) Analysis, 2023-2033 8.3.1. U.S. Market Value (Mn) Forecast, by Product, 2023-2033 8.3.2. U.S. Market Value (Mn) Analysis, 2023-2033 8.3.3. Canada Market Value (Mn) Forecast, by Product, 2023-2033 8.3.4. Canada Market Value (Mn) Analysis, 2023-2033 8.4. North America Market Attractiveness Analysis 9. Europe Market Analysis and Forecast, 2023-2033 9.1. Key Findings 9.2. Europe Market Value (Mn) Forecast, by Product, 2023-2033 9.3. Europe Market Value (Mn) Analysis, 2023-2033 9.3.1. Germany Market Value (Mn) Forecast, by Product, 2023-2033 9.3.2. Germany Market Value (Mn) Analysis, 2023-2033 9.3.3. France Market Value (Mn) Forecast, by Product, 2023-2033 9.3.4. France Market Value (Mn) Analysis, 2023-2033 9.3.5. U.K. Market Value (Mn) Forecast, by Product, 2023-2033 9.3.6. U.K. Market Value (Mn) Analysis, 2023-2033 9.3.7. Italy Market Value (Mn) Forecast, by Product, 2023-2033 9.3.8. Italy Market Value (Mn) Analysis, 2023-2033 9.3.9. Rest of Europe Market Value (Mn) Forecast, by Product, 2023-2033 9.3.10. Rest of Europe Market Value (Mn) Analysis, 2023-2033 9.4. Europe Market Attractiveness Analysis 10. Asia Pacific Market Analysis and Forecast, 2023-2033 10.1. Key Findings 10.2. Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033 10.3. Asia Pacific Market Value (Mn) Analysis, 2023-2033 10.3.1. China Market Value (Mn) Forecast, by Product, 2023-2033 10.3.2. China Market Value (Mn) Analysis, 2023-2033 10.3.3. India Market Value (Mn) Forecast, by Product, 2023-2033 10.3.4. India Market Value (Mn) Analysis, 2023-2033 10.3.5. Japan Market Value (Mn) Forecast, by Product, 2023-2033 10.3.6. Japan Market Value (Mn) Analysis, 2023-2033 10.3.7. ASEAN Market Value (Mn) Forecast, by Product, 2023-2033 10.3.8. ASEAN Market Value (Mn) Analysis, 2023-2033 10.3.9. Rest of Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033 10.3.10. Rest of Asia Pacific Market Value (Mn) Analysis, 2023-2033 10.4. Asia Pacific Market Attractiveness Analysis 11. Latin America Market Analysis and Forecast, 2023-2033 11.1. Key Findings 11.2. Latin America Market Value (Mn) Forecast, by Product, 2023-2033 11.3. Latin America Market Value (Mn) Analysis, 2023-2033 11.3.1. Brazil Market Value (Mn) Forecast, by Product, 2023-2033 11.3.2. Brazil Market Value (Mn) Analysis, 2023-2033 11.3.3. Mexico Market Value (Mn) Forecast, by Product, 2023-2033 11.3.4. Mexico Market Value (Mn) Analysis, 2023-2033 11.3.5. Rest of Latin America Market Value (Mn) Forecast, by Product, 2023-2033 11.3.6. Rest of Latin America Market Value (Mn) Analysis, 2023-2033 11.4. Latin America Market Attractiveness Analysis 12. Middle East & Africa Market Analysis and Forecast, 2023-2033 12.1. Key Findings 12.2. Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033 12.3. Middle East & Africa Market Value (Mn) Analysis, 2023-2033 12.3.1. GCC Market Value (Mn) Forecast, by Product, 2023-2033 12.3.2. GCC Market Value (Mn) Analysis, 2023-2033 12.3.3. South Africa Market Value (Mn) Forecast, by Product, 2023-2033 12.3.4. South Africa Market Value (Mn) Analysis, 2023-2033 12.3.5. Rest of Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033 12.3.6. Rest of Middle East & Africa Market Value (Mn) Analysis, 2023-2033 12.4. Middle East & Africa Market Attractiveness Analysis 13. Competition Landscape 13.1. Global Market Share Analysis, by Company (2022) 13.2. Competition Matrix 13.2.1. Product Mapping 13.3. Company Profiles (Details – Overview, Financials, Recent Developments, and Strategy) 13.3.1. Abbott Laboratories, Inc. 13.3.1.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.1.2. Company Description 13.3.1.3. Business Overview 13.3.1.4. Financial Overview 13.3.1.5. Strategic Overview 13.3.2. Boston Scientific Corporation 13.3.2.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.2.2. Company Description 13.3.2.3. Business Overview 13.3.2.4. Financial Overview 13.3.2.5. Strategic Overview 13.3.3. Medtronic, Inc. 13.3.3.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.3.2. Company Description 13.3.3.3. Business Overview 13.3.3.4. Financial Overview 13.3.3.5. Strategic Overview 13.3.4. Terumo Corporation 13.3.4.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.4.2. Company Description 13.3.4.3. Business Overview 13.3.4.4. Financial Overview 13.3.4.5. Strategic Overview 13.3.5. B. Braun Melsungen AG 13.3.5.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.5.2. Company Description 13.3.5.3. Business Overview 13.3.5.4. Financial Overview 13.3.5.5. Strategic Overview 13.3.6. C. R. Bard, Inc. 13.3.6.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.6.2. Company Description 13.3.6.3. Business Overview 13.3.6.4. Financial Overview 13.3.6.5. Strategic Overview 13.3.7. Cook Medical, Inc. 13.3.7.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.7.2. Company Description 13.3.7.3. Business Overview 13.3.7.4. Financial Overview 13.3.7.5. Strategic Overview 13.3.8. Biotronik SE & Co. KG 13.3.8.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.8.2. Company Description 13.3.8.3. Business Overview 13.3.8.4. Financial Overview 13.3.8.5. Strategic Overview 13.3.9. MicroPort Scientific Corporation 13.3.9.1. Headquarters, Year of Establishment, Revenue, Key Management, Number of Employees 13.3.9.2. Company Description 13.3.9.3. Business Overview 13.3.9.4. Financial Overview 13.3.9.5. Strategic Overview 14. Assumptions & Acronyms Used 15. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (Mn) Forecast, by Product, 2023-2033
Table 02: Global Market Value (Mn) Forecast, by Product, 2023-2033
Table 03: Global Market Value (Mn) Analysis, 2023-2033
Table 04: Global Market Value (Mn) Analysis, 2023-2033
Table 05: Global Market Value (Mn) Forecast, by Region, 2023-2033
Table 06: Global Market Value (Mn) Forecast, by Region, 2023-2033
Table 07: North America Market Value (Mn) Forecast, by Product, 2023-2033
Table 08: North America Market Value (Mn) Forecast, by Product, 2023-2033
Table 09: North America Market Value (Mn) Analysis, 2023-2033
Table 10: North America Market Value (Mn) Analysis, 2023-2033
Table 11: North America Market Value (Mn) Forecast, by Country, 2023-2033
Table 12: North America Market Value (Mn) Forecast, by Country, 2023-2033
Table 13: U.S. Market Value (Mn) Forecast, by Product, 2023-2033
Table 14: U.S. Market Value (Mn) Forecast, by Product, 2023-2033
Table 15: U.S. Market Value (Mn) Analysis, 2023-2033
Table 16: U.S. Market Value (Mn) Analysis, 2023-2033
Table 17: Canada Market Value (Mn) Forecast, by Product, 2023-2033
Table 18: Canada Market Value (Mn) Forecast, by Product, 2023-2033
Table 19: Canada Market Value (Mn) Analysis, 2023-2033
Table 20: Canada Market Value (Mn) Analysis, 2023-2033
Table 21: Europe Market Value (Mn) Forecast, by Product, 2023-2033
Table 22: Europe Market Value (Mn) Forecast, by Product, 2023-2033
Table 23: Europe Market Value (Mn) Analysis, 2023-2033
Table 24: Europe Market Value (Mn) Analysis, 2023-2033
Table 25: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 26: Europe Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 27: Germany Market Value (Mn) Forecast, by Product, 2023-2033
Table 28: Germany Market Value (Mn) Forecast, by Product, 2023-2033
Table 29: Germany Market Value (Mn) Analysis, 2023-2033
Table 30: Germany Market Value (Mn) Analysis, 2023-2033
Table 31: U.K. Market Value (Mn) Forecast, by Product, 2023-2033
Table 32: U.K. Market Value (Mn) Forecast, by Product, 2023-2033
Table 33: U.K. Market Value (Mn) Analysis, 2023-2033
Table 34: U.K. Market Value (Mn) Analysis, 2023-2033
Table 35: France Market Value (Mn) Forecast, by Product, 2023-2033
Table 36: France Market Value (Mn) Forecast, by Product, 2023-2033
Table 37: France Market Value (Mn) Analysis, 2023-2033
Table 38: France Market Value (Mn) Analysis, 2023-2033
Table 39: Italy Market Value (Mn) Forecast, by Product, 2023-2033
Table 40: Italy Market Value (Mn) Forecast, by Product, 2023-2033
Table 41: Italy Market Value (Mn) Analysis, 2023-2033
Table 42: Italy Market Value (Mn) Analysis, 2023-2033
Table 43: Spain Market Value (Mn) Forecast, by Product, 2023-2033
Table 44: Spain Market Value (Mn) Forecast, by Product, 2023-2033
Table 45: Spain Market Value (Mn) Analysis, 2023-2033
Table 46: Spain Market Value (Mn) Analysis, 2023-2033
Table 47: Russia & CIS Market Value (Mn) Forecast, by Product, 2023-2033
Table 48: Russia & CIS Market Value (Mn) Forecast, by Product, 2023-2033
Table 49: Russia & CIS Market Value (Mn) Analysis, 2023-2033
Table 50: Russia & CIS Market Value (Mn) Analysis, 2023-2033
Table 51: Rest of Europe Market Value (Mn) Forecast, by Product, 2023-2033
Table 52: Rest of Europe Market Value (Mn) Forecast, by Product, 2023-2033
Table 53: Rest of Europe Market Value (Mn) Analysis, 2023-2033
Table 54: Rest of Europe Market Value (Mn) Analysis, 2023-2033
Table 55: Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033
Table 56: Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033
Table 57: Asia Pacific Market Value (Mn) Analysis, 2023-2033
Table 58: Asia Pacific Market Value (Mn) Analysis, 2023-2033
Table 59: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 60: Asia Pacific Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 61: China Market Value (Mn) Forecast, by Product, 2023-2033
Table 62: China Market Value (Mn) Forecast, by Product, 2023-2033
Table 63: China Market Value (Mn) Analysis, 2023-2033
Table 64: China Market Value (Mn) Analysis, 2023-2033
Table 65: Japan Market Value (Mn) Forecast, by Product, 2023-2033
Table 66: Japan Market Value (Mn) Forecast, by Product, 2023-2033
Table 67: Japan Market Value (Mn) Analysis, 2023-2033
Table 68: Japan Market Value (Mn) Analysis, 2023-2033
Table 69: India Market Value (Mn) Forecast, by Product, 2023-2033
Table 70: India Market Value (Mn) Forecast, by Product, 2023-2033
Table 71: India Market Value (Mn) Analysis, 2023-2033
Table 72: India Market Value (Mn) Analysis, 2023-2033
Table 73: ASEAN Market Value (Mn) Forecast, by Product, 2023-2033
Table 74: ASEAN Market Value (Mn) Forecast, by Product, 2023-2033
Table 75: ASEAN Market Value (Mn) Analysis, 2023-2033
Table 76: ASEAN Market Value (Mn) Analysis, 2023-2033
Table 77: Rest of Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033
Table 78: Rest of Asia Pacific Market Value (Mn) Forecast, by Product, 2023-2033
Table 79: Rest of Asia Pacific Market Value (Mn) Analysis, 2023-2033
Table 80: Rest of Asia Pacific Market Value (Mn) Analysis, 2023-2033
Table 81: Latin America Market Value (Mn) Forecast, by Product, 2023-2033
Table 82: Latin America Market Value (Mn) Forecast, by Product, 2023-2033
Table 83: Latin America Market Value (Mn) Analysis, 2023-2033
Table 84: Latin America Market Value (Mn) Analysis, 2023-2033
Table 85: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 86: Latin America Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 87: Brazil Market Value (Mn) Forecast, by Product, 2023-2033
Table 88: Brazil Market Value (Mn) Forecast, by Product, 2023-2033
Table 89: Brazil Market Value (Mn) Analysis, 2023-2033
Table 90: Brazil Market Value (Mn) Analysis, 2023-2033
Table 91: Mexico Market Value (Mn) Forecast, by Product, 2023-2033
Table 92: Mexico Market Value (Mn) Forecast, by Product, 2023-2033
Table 93: Mexico Market Value (Mn) Analysis, 2023-2033
Table 94: Mexico Market Value (Mn) Analysis, 2023-2033
Table 95: Rest of Latin America Market Value (Mn) Forecast, by Product, 2023-2033
Table 96: Rest of Latin America Market Value (Mn) Forecast, by Product, 2023-2033
Table 97: Rest of Latin America Market Value (Mn) Analysis, 2023-2033
Table 98: Rest of Latin America Market Value (Mn) Analysis, 2023-2033
Table 99: Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 100: Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 101: Middle East & Africa Market Value (Mn) Analysis, 2023-2033
Table 102: Middle East & Africa Market Value (Mn) Analysis, 2023-2033
Table 103: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 104: Middle East & Africa Market Value (Mn) Forecast, by Country and Sub-region, 2023-2033
Table 105: GCC Market Value (Mn) Forecast, by Product, 2023-2033
Table 106: GCC Market Value (Mn) Forecast, by Product, 2023-2033
Table 107: GCC Market Value (Mn) Analysis, 2023-2033
Table 108: GCC Market Value (Mn) Analysis, 2023-2033
Table 109: South Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 110: South Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 111: South Africa Market Value (Mn) Analysis, 2023-2033
Table 112: South Africa Market Value (Mn) Analysis, 2023-2033
Table 113: Rest of Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 114: Rest of Middle East & Africa Market Value (Mn) Forecast, by Product, 2023-2033
Table 115: Rest of Middle East & Africa Market Value (Mn) Analysis, 2023-2033
Table 116: Rest of Middle East & Africa Market Value (Mn) Analysis, 2023-2033
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Price Trend, by Region, 2023-2033 (US$/Ton)
Figure 02: Global Market Value Share, by Product, 2018, 2023 and 2033
Figure 03: Global Market Attractiveness, by Product
Figure 04: Global Market Value Share, Analysis, 2018, 2023 and 2033
Figure 05: Global Market Attractiveness, Analysis
Figure 06: Global Market Value Share, by Region, 2018, 2023 and 2033
Figure 07: Global Market Attractiveness, by Region
Figure 08: North America Market Value Share, by Product, 2018, 2023 and 2033
Figure 09: North America Market Attractiveness, by Product
Figure 10: North America Market Value Share, Analysis, 2018, 2023 and 2033
Figure 11: North America Market Attractiveness, Analysis
Figure 12: North America Market Value Share, by Country, 2018, 2023 and 2033
Figure 13: North America Market Attractiveness, by Country
Figure 14: Europe Market Value Share, by Product, 2018, 2023 and 2033
Figure 15: Europe Market Attractiveness, by Product
Figure 16: Europe Market Value Share, Analysis, 2018, 2023 and 2033
Figure 17: Europe Market Attractiveness, Analysis
Figure 18: Europe Market Value Share, by Country and Sub-region, 2018, 2023 and 2033
Figure 19: Europe Market Attractiveness, by Country and Sub-region
Figure 20: Asia Pacific Market Value Share, by Product, 2018, 2023 and 2033
Figure 21: Asia Pacific Market Attractiveness, by Product
Figure 22: Asia Pacific Market Value Share, Analysis, 2018, 2023 and 2033
Figure 23: Asia Pacific Market Attractiveness, Analysis
Figure 24: Asia Pacific Market Value Share, by Country and Sub-region, 2018, 2023 and 2033
Figure 25: Asia Pacific Market Attractiveness, by Country and Sub-region
Figure 26: Latin America Market Value Share, by Product, 2018, 2023 and 2033
Figure 27: Latin America Market Attractiveness, by Product
Figure 28: Latin America Market Value Share, Analysis, 2018, 2023 and 2033
Figure 29: Latin America Market Attractiveness, Analysis
Figure 30: Latin America Market Value Share, by Country and Sub-region, 2018, 2023 and 2033
Figure 31: Latin America Market Attractiveness, by Country and Sub-region
Figure 32: Middle East & Africa Market Value Share, by Product, 2018, 2023 and 2033
Figure 33: Middle East & Africa Market Attractiveness, by Product
Figure 34: Middle East & Africa Market Value Share, Analysis, 2018, 2023 and 2033
Figure 35: Middle East & Africa Market Attractiveness, Analysis
Figure 36: Middle East & Africa Market Value Share, by Country and Sub-region, 2018, 2023 and 2033
Figure 37: Middle East & Africa Market Attractiveness, by Country and Sub-region
Figure 38: Global Market Share Analysis, by Company, 2022
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the coronary stents market in 2023?
The global coronary stents market holds a value of US$ 13.7 billion in 2023.
What is the future market analysis for coronary stents?
By the end of 2033, global coronary stent sales are estimated to reach US$ 38.5 billion.
How will demand for coronary stents fare over the next ten years?
From 2023 to 2033, sales of coronary stents are forecasted to rise at an impressive 10.8% CAGR.
Which type of stents are the fastest-selling in the market?
Drug eluting stent sales currently account for around 80% of the global market share.
Who are the leading coronary stent suppliers?
Abbott Laboratories Inc., Boston Scientific Corporation, Medtronic Inc., and Terumo Corporation are leading companies manufacturing coronary stents.
Which regional market dominates the global landscape?
Coronary stent sales in North America account for around 30% share of the global industry.
Coronary Stents Market